Opportunity
Simpler Grants.gov #RFA-AI-27-014
NIH Seeks R&D Proposals for Medical Countermeasures Against Chemical and Radiation/Nuclear Threats
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
October 09, 2026
Identifier
RFA-AI-27-014
NAICS
541715, 541714
This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks research and development proposals for medical countermeasures and technologies against chemical or radiation/nuclear threats. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Administered through the Radiation and Nuclear Countermeasures Program (RNCP) and Chemical Countermeasures Research Program (CCRP) - Products/Services Requested: - Research and development of candidate medical countermeasures (MCMs) and technologies - Focus on models, biomarkers, assessment devices, and products to improve survival and reduce morbidity from radiation or chemical exposure - Emphasis on preclinical research for post-exposure, mass casualty civilian scenarios - Unique/Notable Requirements: - No specific OEMs, vendors, part numbers, or quantities specified - Open to a wide range of applicants: government, nonprofit, business, educational, tribal, and faith-based organizations - Projects should address government-designated chemicals of concern and/or radiation/nuclear threats - Cooperative agreement mechanism (not a standard contract or purchase) - OEMs: - No OEMs or commercial manufacturers are specified, as this is a research grant opportunity
Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support research on concepts and technologies to address civilian radiation or chemical threats. The research focuses on developing new ideas and technologies to diagnose, mitigate, and treat acute and delayed effects of radiation or chemical exposures during and after a public health emergency. The Radiation and Nuclear Countermeasures Program (RNCP) supports development of radiation-focused models, biomarkers, devices, and products to improve survival and reduce morbidity. The Chemical Countermeasures Research Program (CCRP) supports preclinical work on products to mitigate and treat injuries after exposure to government-designated Chemicals of Concern in a post-exposure, civilian mass casualty setting.